Pneumococcal septic shock after neonatal respiratory syncytial virus bronchiolitis: A case report and literature review

Main Article Content

Antonella Di Caprio
Elena Coccolini
Paola Zagni
Eleonora Vaccina
Laura Lucaccioni
Licia Lugli
Lorenzo Iughetti
Alberto Berardi


Respiratory syncytial virus, Bronchiolitis, Streptococcus pneumoniae, Newborn, Antibiotic therapy, Case report


Background: Bronchiolitis is a common cause of hospitalisation of infants less than a year old, with most infants recovering without complications. Respiratory syncytial virus (RSV) is a leading cause of bronchiolitis. Antimicrobial stewardship programmes do not recommend antibiotics for viral infections in neonates unless documented evidence of secondary bacterial infection is present. Case report: We present the case of a 7-day-old infant admitted to hospital with chest retractions and fever. The baby was hospitalised, empirical antibiotic therapy was administered, and non-invasive ventilation was started. When the viral aetiology was identified and clinical conditions improved, antibiotics were discontinued. However, after 48 hours, the newborn's condition worsened because of pneumococcal septic shock. Intravenous fluids, catecholamine support, and wide-spectrum antibiotics were administered. Non-invasive ventilation was re-started and continued until the full recovery. Conclusions: There is increasing evidence that RSV and S. pneumoniae co-infect and interact with each other, thus increasing respiratory diseases' severity. We provide a brief overview of the main international guidelines for managing bronchiolitis. Guidelines suggest avoidance of antibiotics use when the diagnosis of viral bronchiolitis is confirmed. We discuss the uncertainties regarding antibiotic use, especially in younger infants, who are more exposed to risks of bacterial superinfection.


Download data is not yet available.
Abstract 440 | PDF Downloads 248


1. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588-598. doi:10.1056/NEJMoa0804877
2. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis [published correction appears in Pediatrics. 2015 Oct;136(4):782]. Pediatrics. 2014;134(5):e1474-e1502. doi:10.1542/peds.2014-2742
3. Mansbach JM, Piedra PA, Stevenson MD, et al. Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation. Pediatrics. 2012;130(3):e492-e500. doi:10.1542/peds.2012-0444
4. Berardi A, Sforza F, Baroni L, et al. (2019) Epidemiology and complications of late-onset sepsis: an Italian area-based study. PLoS ONE 14(11): e0225407.
5. Soto-Noguerón A, Carnalla-Barajas MN, Solórzano-Santos F, et al. Streptococcus pneumoniae as cause of infection in infants less than 60 days of age: serotypes and antimicrobial susceptibility. Int J Infect Dis. 2016;42:69-73. doi:10.1016/j.ijid.2015.12.001
6. Hoffman JA, Mason EO, Schutze GE, et al. Streptococcus pneumoniae infections in the neonate. Pediatrics. 2003;112(5):1095-1102. doi:10.1542/peds.112.5.1095
7. Stark JM, Stark MA, Colasurdo GN, LeVine AM. Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection. J Med Virol. 2006;78(6):829-838. doi:10.1002/jmv.20631
8. Hament JM, Aerts PC, Fleer A, et al. Enhanced adherence of Streptococcus pneumoniae to human epithelial cells infected with respiratory syncytial virus. Pediatr Res. 2004;55(6):972-978. doi:10.1203/01.PDR.0000127431.11750.D9
9. Hament JM, Aerts PC, Fleer A, et al. Direct binding of respiratory syncytial virus to pneumococci: a phenomenon that enhances both pneumococcal adherence to human epithelial cells and pneumococcal invasiveness in a murine model. Pediatr Res. 2005;58(6):1198-1203. doi:10.1203/01.pdr.0000188699.55279.1b.
10. Elahmer OR, Raza MW, Ogilvie MM, Blackwell CC, Weir DM, Elton RA. The effect of respiratory virus infection on expression of cell surface antigens associated with binding of potentially pathogenic bacteria. Adv Exp Med Biol. 1996;408:169-177. doi:10.1007/978-1-4613-0415-9_19
11. Ramos-Fernández JM, Moreno-Pérez D, Gutiérrez-Bedmar M, et al. Predicción de la evolución de la bronquiolitis por virus respiratorio sincitial en lactantes menores de 6 meses [Prediction of Severe Course in Infants with RSV Bronchiolitis under 6 Months. Spain]. Rev Esp Salud Publica. 2017;91:e201701006.
12. Brealey JC, Sly PD, Young PR, Chappell KJ. Analysis of phylogenetic diversity and in vitro adherence characteristics of respiratory syncytial virus and Streptococcus pneumoniae clinical isolates obtained during pediatric respiratory co-infections. Microbiology (Reading). 2020;166(1):63-72. doi:10.1099/mic.0.000870
13. Zaidi AK, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J. 2009;28(1 Suppl):S10-S18. doi:10.1097/INF.0b013e3181958769
14. Baş AY, Demirel N, Aydin M, Zenciroglu A, Tonbul A, Tanir G. Pneumococcal meningitis in the newborn period in a prevaccination era: a 10-year experience at a tertiary intensive care unit. Turk J Pediatr. 2011;53(2):142-148.
15. Coles CL, Rahmathullah L, Kanungo R, et al. Pneumococcal carriage at age 2 months is associated with growth deficits at age 6 months among infants in South India. J Nutr. 2012;142(6):1088-1094. doi:10.3945/jn.111.156844
16. Smith CM, Sandrini S, Datta S, et al. Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection. Am J Respir Crit Care Med. 2014;190(2):196-207. doi:10.1164/rccm.201311-2110OC
17. Yan T, Tang X, Sun L, Tian R, Li Z, Liu G. Co infection of respiratory syncytial viruses (RSV) and streptococcus pneumonia modulates pathogenesis and dependent of serotype and phase variant. Microb Pathog. 2020;144:104126. doi:10.1016/j.micpath.2020.104126
18. Baraldi E, Lanari M, Manzoni P, et al. Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr. 2014;40:65. Published 2014 Oct 24. doi:10.1186/1824-7288-40-65
19. Kneyber MC, van Woensel JB, Uijtendaal E, Uiterwaal CS, Kimpen JL; Dutch Antibiotics in RSV Trial (DART) Research Group. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial. Pediatr Pulmonol. 2008;43(2):142-149. doi:10.1002/ppul.20748
20. Vogel AM, Lennon DR, Harding JE, et al. Variations in bronchiolitis management between five New Zealand hospitals: can we do better?. J Paediatr Child Health. 2003;39(1):40-45. doi:10.1046/j.1440-1754.2003.00069.x
21. Kabir AR, Mollah AH, Anwar KS, Rahman AK, Amin R, Rahman ME. Management of bronchiolitis without antibiotics: a multicentre randomized control trial in Bangladesh. Acta Paediatr. 2009;98(10):1593-1599. doi:10.1111/j.1651-2227.2009.01389.x
22. Farley R, Spurling GK, Eriksson L, Del Mar CB. Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev. 2014;(10):CD005189. Published 2014 Oct 9. doi:10.1002/14651858.CD005189.pub4
23. Green M, Brayer AF, Schenkman KA, Wald ER. Duration of hospitalization in previously well infants with respiratory syncytial virus infection. Pediatr Infect Dis J. 1989;8(9):601-605. doi:10.1097/00006454-198909000-00007
24. Pruikkonen H, Uhari M, Dunder T, Pokka T, Renko M. Infants under 6 months with bronchiolitis are most likely to need major medical interventions in the 5 days after onset. Acta Paediatr. 2014;103(10):1089-1093. doi:10.1111/apa.12704.
25. Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child. 2003;88(12):1065-1069. doi:10.1136/adc.88.12.1065
26. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1995;126(2):212-219. doi:10.1016/s0022-3476(95)70547-3
27. Opavsky MA, Stephens D, Wang EE. Testing models predicting severity of respiratory syncytial virus infection on the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada. Arch Pediatr Adolesc Med. 1995;149(11):1217-1220. doi:10.1001/archpedi.1995.02170240035005
28. Verstraete M, Cros P, Gouin M, et al. Prise en charge de la bronchiolite aiguë du nourrisson de moins de 1 an : actualisation et consensus médical au sein des hôpitaux universitaires du Grand Ouest (HUGO) [Update on the management of acute viral bronchiolitis: proposed guidelines of Grand Ouest University Hospitals]. Arch Pediatr. 2014;21(1):53-62. doi:10.1016/j.arcped.2013.10.020

Most read articles by the same author(s)

1 2 > >>